Nomura Holdings’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
S
Nomura Holdings's NVAX Position: Q2 2026 in Review
Nomura Holdings reduced its Novavax (NVAX) stake by 39% in Q2 2026, selling an estimated $316K and leaving 55,683 shares worth $525K. The position accounts for ﹤0.01% of the portfolio, ranked #1500.
Nomura Holdings first reported a position in NVAX in Q2 2013 and has held it in 16 quarters since. The position peaked at $4.95M in Q4 2021. 247 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Nomura Holdings held 55,683 shares of Novavax worth $525K as of Q2 2026.
- Nomura Holdings sold 35,213 Novavax shares in Q2 2026, an estimated $316K.
- Novavax made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1500 holding.
- Nomura Holdings first reported a position in Novavax in Q2 2013 and has held it in 16 quarters since.
- Nomura Holdings's Novavax position peaked at $4.95M in Q4 2021.
- 247 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.